. advertisement .china's plans to import indian drugs fail to enthuse indian pharmaceutical firms . .hide comments . . cambridge's bluebird bio licenses delivery tech to novartis, gsk .-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018. .: "fremanezumab for the preventive treatment of chronic migraine." http://lm360.us/Agan-son-of-Cacal-from-Iwaki?Feulnermo=196 .suicidal thoughts, attempts on the rise among young people: 'it's a critical public-health crisis right now' . .the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid. . . . .a genetic disorder that leads to underdeveloped sweat glands and teeth was treated in the womb .